Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Open-market sale 10% owner sold 101,994 shares at an average $50.68 ($5,168,901)
  2. 4 Open-market sale Director sold 101,994 shares at an average $50.68 ($5,168,901)
  3. 4 Open-market sale Director sold 101,994 shares at an average $50.68 ($5,168,901)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market buy 10% owner bought 527,472 shares at $22.75 ($11,999,988)
  11. 4 Open-market sale Chief Legal Officer sold 66,000 shares at an average $28.03 ($1,850,255)
  12. 4 Open-market buy Director bought 65,934 shares at $22.75 ($1,499,999)
  13. 4 Open-market sale Director sold 92,337 shares at $26.96 ($2,489,406)
  14. 4 Open-market sale Chief Legal Officer sold 38,000 shares at an average $21.64 ($822,500)
  15. 4 Open-market sale Director sold 37,754 shares at $26.76 ($1,010,123)
  16. 4 Open-market sale Chief Legal Officer sold 31,000 shares at an average $22.72 ($704,280)
  17. 4 Open-market sale Chief Legal Officer sold 15,000 shares at $20.55 ($308,250)
  18. 4 Open-market sale Director sold 26,016 shares at $20.30 ($528,237)
  19. 4 Open-market sale Director sold 3,059 shares at $20.29 ($62,070)
  20. 4 Exercise or conversion Chief Executive Officer acquired 15,000 shares (option exercise)

Page 20 of 26 · 502 filings